Selected research
Market Structure
Global Anti-aging and Longevity Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-aging and Longevity Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-aging and Longevity Drugs include Centrum, GNC, Herbalmax, HUM Nutrition, MegaFood, Natrol, Nature Made, Nature's Bounty and New Chapter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-aging and Longevity Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-aging and Longevity Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-aging and Longevity Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-aging and Longevity Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-aging and Longevity Drugs Segment by Company
Centrum
GNC
Herbalmax
HUM Nutrition
MegaFood
Natrol
Nature Made
Nature's Bounty
New Chapter
Pure Encapsulations
The Vitamin Shoppe
China Resources Double-Crane Pharmaceutical Co.,Ltd.
GeneHarbor (Hong Kong) Biotechnologies Limited
Xiamen Kingdomway Group Company
Shinkowa
Yaben Chemical
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
Anti-aging and Longevity Drugs Segment by Type
Resveratrol
Coenzyme Q10 and Collagen
Biotin
Vitamins
Nicotinamide Mononucleotide (NMN)
Others
Anti-aging and Longevity Drugs Segment by Application
Retail Pharmacies
Online Pharmacies
Hospitals
Clinics
Anti-aging and Longevity Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-aging and Longevity Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-aging and Longevity Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-aging and Longevity Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-aging and Longevity Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-aging and Longevity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-aging and Longevity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Anti-aging and Longevity Drugs Industry Trends
Table 2. Anti-aging and Longevity Drugs Industry Drivers
Table 3. Anti-aging and Longevity Drugs Industry Opportunities and Challenges
Table 4. Anti-aging and Longevity Drugs Industry Restraints
Table 5. Global Anti-aging and Longevity Drugs Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Anti-aging and Longevity Drugs Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Anti-aging and Longevity Drugs Sales by Manufacturers (K Units) & (2021-2026)
Table 8. Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers
Table 9. Global Anti-aging and Longevity Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Anti-aging and Longevity Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Anti-aging and Longevity Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Anti-aging and Longevity Drugs Manufacturers, Product Type & Application
Table 13. Global Anti-aging and Longevity Drugs Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anti-aging and Longevity Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Resveratrol
Table 17. Major Manufacturers of Coenzyme Q10 and Collagen
Table 18. Major Manufacturers of Biotin
Table 19. Major Manufacturers of Vitamins
Table 20. Major Manufacturers of Nicotinamide Mononucleotide (NMN)
Table 21. Major Manufacturers of Others
Table 22. Global Anti-aging and Longevity Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 23. Global Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units)
Table 24. Global Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units)
Table 25. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2026)
Table 26. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2027-2032)
Table 27. Global Anti-aging and Longevity Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units)
Table 28. Global Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (K Units)
Table 29. Global Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (K Units)
Table 30. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2027-2032)
Table 32. Major Manufacturers of Retail Pharmacies
Table 33. Major Manufacturers of Online Pharmacies
Table 34. Major Manufacturers of Hospitals
Table 35. Major Manufacturers of Clinics
Table 36. Global Anti-aging and Longevity Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 37. Global Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units)
Table 38. Global Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units)
Table 39. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2026)
Table 40. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2027-2032)
Table 41. Global Anti-aging and Longevity Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units)
Table 42. Global Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (K Units)
Table 43. Global Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (K Units)
Table 44. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2026)
Table 45. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2027-2032)
Table 46. Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 47. Global Anti-aging and Longevity Drugs Sales by Region (2021-2026) & (K Units)
Table 48. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2026)
Table 49. Global Anti-aging and Longevity Drugs Sales Forecasted by Region (2027-2032) & (K Units)
Table 50. Global Anti-aging and Longevity Drugs Sales Forecasted Market Share by Region (2027-2032)
Table 51. North America Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 52. North America Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units)
Table 53. North America Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units)
Table 54. Europe Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 55. Europe Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units)
Table 56. Europe Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units)
Table 57. Asia Pacific Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 58. Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units)
Table 59. Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units)
Table 60. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 61. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units)
Table 62. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units)
Table 63. Global Anti-aging and Longevity Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 64. Global Anti-aging and Longevity Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 65. Global Anti-aging and Longevity Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 66. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2026)
Table 67. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2027-2032)
Table 68. Centrum Company Information
Table 69. Centrum Business Overview
Table 70. Centrum Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Centrum Anti-aging and Longevity Drugs Product Portfolio
Table 72. Centrum Recent Development
Table 73. GNC Company Information
Table 74. GNC Business Overview
Table 75. GNC Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. GNC Anti-aging and Longevity Drugs Product Portfolio
Table 77. GNC Recent Development
Table 78. Herbalmax Company Information
Table 79. Herbalmax Business Overview
Table 80. Herbalmax Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Herbalmax Anti-aging and Longevity Drugs Product Portfolio
Table 82. Herbalmax Recent Development
Table 83. HUM Nutrition Company Information
Table 84. HUM Nutrition Business Overview
Table 85. HUM Nutrition Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
Table 87. HUM Nutrition Recent Development
Table 88. MegaFood Company Information
Table 89. MegaFood Business Overview
Table 90. MegaFood Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. MegaFood Anti-aging and Longevity Drugs Product Portfolio
Table 92. MegaFood Recent Development
Table 93. Natrol Company Information
Table 94. Natrol Business Overview
Table 95. Natrol Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 96. Natrol Anti-aging and Longevity Drugs Product Portfolio
Table 97. Natrol Recent Development
Table 98. Nature Made Company Information
Table 99. Nature Made Business Overview
Table 100. Nature Made Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 101. Nature Made Anti-aging and Longevity Drugs Product Portfolio
Table 102. Nature Made Recent Development
Table 103. Nature's Bounty Company Information
Table 104. Nature's Bounty Business Overview
Table 105. Nature's Bounty Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 106. Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
Table 107. Nature's Bounty Recent Development
Table 108. New Chapter Company Information
Table 109. New Chapter Business Overview
Table 110. New Chapter Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 111. New Chapter Anti-aging and Longevity Drugs Product Portfolio
Table 112. New Chapter Recent Development
Table 113. Pure Encapsulations Company Information
Table 114. Pure Encapsulations Business Overview
Table 115. Pure Encapsulations Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 116. Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
Table 117. Pure Encapsulations Recent Development
Table 118. The Vitamin Shoppe Company Information
Table 119. The Vitamin Shoppe Business Overview
Table 120. The Vitamin Shoppe Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 121. The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
Table 122. The Vitamin Shoppe Recent Development
Table 123. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
Table 124. China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
Table 125. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 126. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
Table 127. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Development
Table 128. GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
Table 129. GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
Table 130. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 131. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
Table 132. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Development
Table 133. Xiamen Kingdomway Group Company Company Information
Table 134. Xiamen Kingdomway Group Company Business Overview
Table 135. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 136. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
Table 137. Xiamen Kingdomway Group Company Recent Development
Table 138. Shinkowa Company Information
Table 139. Shinkowa Business Overview
Table 140. Shinkowa Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 141. Shinkowa Anti-aging and Longevity Drugs Product Portfolio
Table 142. Shinkowa Recent Development
Table 143. Yaben Chemical Company Information
Table 144. Yaben Chemical Business Overview
Table 145. Yaben Chemical Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 146. Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
Table 147. Yaben Chemical Recent Development
Table 148. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
Table 149. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
Table 150. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 151. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
Table 152. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Development
Table 153. Key Raw Materials
Table 154. Raw Materials Key Suppliers
Table 155. Anti-aging and Longevity Drugs Distributors List
Table 156. Anti-aging and Longevity Drugs Customers List
Table 157. Research Programs/Design for This Report
Table 158. Authors List of This Report
Table 159. Secondary Sources
Table 160. Primary Sources
List of Figures
Figure 1. Anti-aging and Longevity Drugs Product Image
Figure 2. Global Anti-aging and Longevity Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-aging and Longevity Drugs Market Size (2021-2032) & (US$ Million)
Figure 4. Global Anti-aging and Longevity Drugs Sales (2021-2032) & (K Units)
Figure 5. Global Anti-aging and Longevity Drugs Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Anti-aging and Longevity Drugs Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Resveratrol Image
Figure 9. Coenzyme Q10 and Collagen Image
Figure 10. Biotin Image
Figure 11. Vitamins Image
Figure 12. Nicotinamide Mononucleotide (NMN) Image
Figure 13. Others Image
Figure 14. Global Anti-aging and Longevity Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 15. Global Anti-aging and Longevity Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 16. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032)
Figure 17. Global Anti-aging and Longevity Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 18. Global Anti-aging and Longevity Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 19. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032)
Figure 20. Retail Pharmacies Image
Figure 21. Online Pharmacies Image
Figure 22. Hospitals Image
Figure 23. Clinics Image
Figure 24. Global Anti-aging and Longevity Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 25. Global Anti-aging and Longevity Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 26. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032)
Figure 27. Global Anti-aging and Longevity Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 28. Global Anti-aging and Longevity Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 29. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032)
Figure 30. North America Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 31. North America Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032)
Figure 32. U.S. Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 33. Canada Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 34. Mexico Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 35. Europe Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 36. Europe Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032)
Figure 37. Germany Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 38. France Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 39. U.K. Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 40. Italy Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 41. Netherlands Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 42. Asia Pacific Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 43. Asia Pacific Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032)
Figure 44. China Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 45. Japan Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 46. South Korea Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 47. Southeast Asia Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 48. India Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 49. Australia Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 50. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 51. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032)
Figure 52. Brazil Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 53. South Africa Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 54. Saudi Arabia Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 55. Turkey Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 56. Argentina Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 57. UAE Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 58. Egypt Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 59. Chile Anti-aging and Longevity Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 60. Global Anti-aging and Longevity Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 61. Global Anti-aging and Longevity Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 62. North America Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million)
Figure 63. North America Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 64. Europe Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million)
Figure 65. Europe Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 66. Asia-Pacific Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million)
Figure 67. Asia-Pacific Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 68. South America, Middle East and Africa Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million)
Figure 69. South America, Middle East and Africa Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 70. Anti-aging and Longevity Drugs Value Chain
Figure 71. Manufacturing Cost Structure
Figure 72. Anti-aging and Longevity Drugs Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
Scope & coverage.
Types
- Resveratrol
- Coenzyme Q10 and Collagen
- Biotin
- Vitamins
- Nicotinamide Mononucleotide (NMN)
- Others
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospitals
- Clinics
Companies covered
- Centrum
- GNC
- Herbalmax
- HUM Nutrition
- MegaFood
- Natrol
- Nature Made
- Nature's Bounty
- New Chapter
- Pure Encapsulations
- The Vitamin Shoppe
- China Resources Double-Crane Pharmaceutical Co.,Ltd.
- GeneHarbor (Hong Kong) Biotechnologies Limited
- Xiamen Kingdomway Group Company
- Shinkowa
- Yaben Chemical
- Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-aging and Longevity Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-aging and Longevity Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-aging and Longevity Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-aging and Longevity Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-aging and Longevity Drugs Market Dynamics
- 2.1 Anti-aging and Longevity Drugs Industry Trends
- 2.2 Anti-aging and Longevity Drugs Industry Drivers
- 2.3 Anti-aging and Longevity Drugs Industry Opportunities and Challenges
- 2.4 Anti-aging and Longevity Drugs Industry Restraints
3 Anti-aging and Longevity Drugs Market by Manufacturers
- 3.1 Global Anti-aging and Longevity Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-aging and Longevity Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-aging and Longevity Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-aging and Longevity Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-aging and Longevity Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-aging and Longevity Drugs Manufacturers, Product Type & Application
- 3.7 Global Anti-aging and Longevity Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-aging and Longevity Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-aging and Longevity Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-aging and Longevity Drugs Tier 1, Tier 2, and Tier 3
4 Anti-aging and Longevity Drugs Market by Type
- 4.1 Anti-aging and Longevity Drugs Type Introduction
- 4.1.1 Resveratrol
- 4.1.2 Coenzyme Q10 and Collagen
- 4.1.3 Biotin
- 4.1.4 Vitamins
- 4.1.5 Nicotinamide Mononucleotide (NMN)
- 4.1.6 Others
- 4.2 Global Anti-aging and Longevity Drugs Sales by Type
- 4.2.1 Global Anti-aging and Longevity Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-aging and Longevity Drugs Sales by Type (2021-2032)
- 4.2.3 Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-aging and Longevity Drugs Revenue by Type
- 4.3.1 Global Anti-aging and Longevity Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032)
5 Anti-aging and Longevity Drugs Market by Application
- 5.1 Anti-aging and Longevity Drugs Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospitals
- 5.1.4 Clinics
- 5.2 Global Anti-aging and Longevity Drugs Sales by Application
- 5.2.1 Global Anti-aging and Longevity Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-aging and Longevity Drugs Sales by Application (2021-2032)
- 5.2.3 Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-aging and Longevity Drugs Revenue by Application
- 5.3.1 Global Anti-aging and Longevity Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-aging and Longevity Drugs Sales by Region
- 6.1 Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-aging and Longevity Drugs Sales by Region (2021-2032)
- 6.2.1 Global Anti-aging and Longevity Drugs Sales by Region (2021-2026)
- 6.2.2 Global Anti-aging and Longevity Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-aging and Longevity Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-aging and Longevity Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-aging and Longevity Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-aging and Longevity Drugs Revenue by Region
- 7.1 Global Anti-aging and Longevity Drugs Revenue by Region
- 7.1.1 Global Anti-aging and Longevity Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-aging and Longevity Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Anti-aging and Longevity Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-aging and Longevity Drugs Revenue (2021-2032)
- 7.2.2 North America Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-aging and Longevity Drugs Revenue (2021-2032)
- 7.3.2 Europe Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-aging and Longevity Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-aging and Longevity Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-aging and Longevity Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Centrum
- 8.1.1 Centrum Company Information
- 8.1.2 Centrum Business Overview
- 8.1.3 Centrum Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
- 8.1.5 Centrum Recent Developments
- 8.2 GNC
- 8.2.1 GNC Company Information
- 8.2.2 GNC Business Overview
- 8.2.3 GNC Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GNC Anti-aging and Longevity Drugs Product Portfolio
- 8.2.5 GNC Recent Developments
- 8.3 Herbalmax
- 8.3.1 Herbalmax Company Information
- 8.3.2 Herbalmax Business Overview
- 8.3.3 Herbalmax Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
- 8.3.5 Herbalmax Recent Developments
- 8.4 HUM Nutrition
- 8.4.1 HUM Nutrition Company Information
- 8.4.2 HUM Nutrition Business Overview
- 8.4.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
- 8.4.5 HUM Nutrition Recent Developments
- 8.5 MegaFood
- 8.5.1 MegaFood Company Information
- 8.5.2 MegaFood Business Overview
- 8.5.3 MegaFood Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
- 8.5.5 MegaFood Recent Developments
- 8.6 Natrol
- 8.6.1 Natrol Company Information
- 8.6.2 Natrol Business Overview
- 8.6.3 Natrol Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
- 8.6.5 Natrol Recent Developments
- 8.7 Nature Made
- 8.7.1 Nature Made Company Information
- 8.7.2 Nature Made Business Overview
- 8.7.3 Nature Made Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
- 8.7.5 Nature Made Recent Developments
- 8.8 Nature's Bounty
- 8.8.1 Nature's Bounty Company Information
- 8.8.2 Nature's Bounty Business Overview
- 8.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
- 8.8.5 Nature's Bounty Recent Developments
- 8.9 New Chapter
- 8.9.1 New Chapter Company Information
- 8.9.2 New Chapter Business Overview
- 8.9.3 New Chapter Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
- 8.9.5 New Chapter Recent Developments
- 8.10 Pure Encapsulations
- 8.10.1 Pure Encapsulations Company Information
- 8.10.2 Pure Encapsulations Business Overview
- 8.10.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
- 8.10.5 Pure Encapsulations Recent Developments
- 8.11 The Vitamin Shoppe
- 8.11.1 The Vitamin Shoppe Company Information
- 8.11.2 The Vitamin Shoppe Business Overview
- 8.11.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
- 8.11.5 The Vitamin Shoppe Recent Developments
- 8.12 China Resources Double-Crane Pharmaceutical Co.,Ltd.
- 8.12.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
- 8.12.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
- 8.12.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
- 8.12.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments
- 8.13 GeneHarbor (Hong Kong) Biotechnologies Limited
- 8.13.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
- 8.13.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
- 8.13.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
- 8.13.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments
- 8.14 Xiamen Kingdomway Group Company
- 8.14.1 Xiamen Kingdomway Group Company Company Information
- 8.14.2 Xiamen Kingdomway Group Company Business Overview
- 8.14.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
- 8.14.5 Xiamen Kingdomway Group Company Recent Developments
- 8.15 Shinkowa
- 8.15.1 Shinkowa Company Information
- 8.15.2 Shinkowa Business Overview
- 8.15.3 Shinkowa Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
- 8.15.5 Shinkowa Recent Developments
- 8.16 Yaben Chemical
- 8.16.1 Yaben Chemical Company Information
- 8.16.2 Yaben Chemical Business Overview
- 8.16.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
- 8.16.5 Yaben Chemical Recent Developments
- 8.17 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
- 8.17.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
- 8.17.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
- 8.17.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
- 8.17.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-aging and Longevity Drugs Value Chain Analysis
- 9.1.1 Anti-aging and Longevity Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-aging and Longevity Drugs Production Mode & Process
- 9.2 Anti-aging and Longevity Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-aging and Longevity Drugs Distributors
- 9.2.3 Anti-aging and Longevity Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst